Active substanceBromhexineBromhexine
Similar drugsTo uncover
  • Bromhexine
    syrup inwards 
    ROSLEKS PHARM, LLC     Russia
  • Bromhexine
    pills inwards 
  • Bromhexine
    pills inwards 
  • Bromhexine
    solution inwards 
    ATOLL, LLC     Russia
  • Bromhexine
    solution inwards 
  • Bromhexine
    pills inwards 
    BIOSINTEZ, PAO     Russia
  • Bromhexine
    pills inwards 
  • Bromhexine
    pills inwards 
    UPDATE OF PFC, CJSC     Russia
  • Bromhexine
    syrup inwards 
  • Bromhexine
    pills inwards 
    DALHIMFARM, OJSC     Russia
  • Bromhexine
    pills inwards 
    ATOLL, LLC     Russia
  • Bromhexine
    pills inwards 
  • Bromhexine
    pills inwards d / children 
    ATOLL, LLC     Russia
  • Bromhexine 4 Berlin-Chemie
    solution inwards 
    Berlin-Chemie, AG     Germany
  • Bromhexine 8
    drops inwards 
  • Bromhexine 8 Berlin-Chemie
    pills inwards 
    Berlin-Chemie, AG     Germany
  • Bromhexine Grindeks
    pills inwards 
    GRINDEX, JSC     Latvia
  • Bromhexine Grindeks
    syrup inwards 
    GRINDEX, JSC     Latvia
  • Bromhexine MS
    pills inwards 
    MEDISORB, CJSC     Russia
  • Takeda Pharma A / S     Denmark
  • Bromgeksin Obolenskoe
    pills inwards 
  • Bromhexine-Abrichin
    syrup inwards 
    AKRIKHIN HFK, JSC     Russia
  • Bromhexine-Abrichin
    pills inwards 
    AKRIKHIN HFK, JSC     Russia
  • Bromhexine-UBF
    pills inwards 
    URALBIOFARM, OJSC     Russia
  • Bronchostop
    syrup inwards 
  • Solvin®
    solution inwards 
  • Solvin®
    pills inwards 
  • Dosage form: & nbsppills
    Composition:

    1 tablet contains

    Active substance: bromhexine hydrochloride 8 mg

    Excipients: lactose (sugar milk), povidone, potato starch, microcrystalline cellulose, magnesium stearate.

    Description:

    Tablets of white color are flat-faced with a facet and a risk.

    Pharmacotherapeutic group:Mucolytic expectorant
    ATX: & nbsp

    R.05.C.B   Mucolytics

    R.05.C.B.02   Bromhexine

    Pharmacodynamics:

    Mucolytic (secretolitic), has an expectorant and weak antitussive effect. Reduces the viscosity of sputum (depolymerizes mucoprotein and mucopolysaccharide fibers, increases the serous component of the bronchial secretion); activates the ciliated epithelium., increases, volume and improves sputum discharge.Stimulates the production of endogenous surfactant, which ensures the stability of alveolar cells in the process of breathing. The effect is manifested after 2-5 days from the beginning of treatment.

    Pharmacokinetics:

    Ingestion bromohexine almost completely (99%) is absorbed in the gastrointestinal tract for 30 minutes. Bioavailability - about 80 % due to the effect of "first passage" through the liver. In the plasma bromohexine binds to proteins, penetrates through blood-brain and placental barriers. In the liver bromohexine is subjected to demethylation and oxidation. The half-life is 15 hours due to slow reverse diffusion from the tissues. Excreted by the kidneys. In chronic renal failure, the release of metabolites of bromhexine is disrupted. With repeated use bromohexine can cumulate.

    Indications:

    Diseases of the respiratory tract, accompanied by difficulty in moving away viscous sputum: tracheobronchitis, bronchitis of different etiology (including complicated by bronchiectasis), bronchial asthma, pulmonary tuberculosis, pneumonia, cystic fibrosis.

    Sanitation of the bronchial tree in the preoperative period and during medical and diagnosticintrabronchial manipulation, prevention of congestion in the bronchi of thick viscous sputum after surgery.

    Contraindications:

    Hypersensitivity to the components of the drug, peptic ulcer of the stomach, pregnancy (1 trimester), lactation period, children's age (up to 3 years).

    Carefully:

    Renal and / or liver failure; bronchial diseases, accompanied by excessive accumulation of secretion, in the anamnesis - gastric bleeding.

    Dosing and Administration:

    Inside, regardless of food intake. Adults and children over 14 years of age - 8-16 mg 3-4 times a day, children from 6 to 14 years - 8 mg 3 times a day. If necessary, the adult dose can be increased to 16 mg 4 times a day. Children 3-6 years 4 mg 1/2 tablets 3 times a day. Therapeutic effect may appear on the 4-6th day of treatment.

    The course of treatment is from 4 to 28 days.

    Patients with renal insufficiency are prescribed smaller doses or increase the interval between administrations.

    Side effects:

    Allergic reactions, nausea, vomiting, exacerbation of peptic ulcer and duodenal ulcer, dizziness, headache, increased activity of "liver" transaminases (extremely rare).

    Overdose:

    Symptoms: nausea, vomiting, diarrhea.

    Treatment: artificial vomiting, gastric lavage (in the first 1-2 hours after administration).

    Interaction:

    Bromhexine Do not prescribe concomitantly with drugs that suppress the cough center (incl. codeine), as this makes it difficult to escape the diluted sputum (bronchial secretion in the respiratory tract).

    Bromhexine is incompatible with alkaline solutions.

    Bromhexine contributes to the penetration of antibiotics (amoxicillin, erythromycin, cephalexin, oxytetracycline), sulfonamide drugs in the bronchial secret in the first 4-5 days of antimicrobial therapy.

    Special instructions:

    When treating, you must take a sufficient amount of fluid, which increases the expectorant effect of bromhexine.

    In children, treatment should be combined with postural drainage or vibratory chest massage, which facilitates the secretion of bronchial secretions.

    Form release / dosage:

    Tablets of 8 mg.

    Packaging:

    For 10 tablets in a contour mesh package made of a polyvinyl chloride orange film and aluminum foil printed lacquered.

    5 contour packs together with instructions for use in a pack of cardboard.

    For 600 or 1000 contour packs of 10 tablets together with an equal number of instructions for use in cardboard boxes.

    Storage conditions:

    In a dry, protected from light place at a temperature of no higher than 25 ° C. Keep out of the reach of children.

    Shelf life:

    3 years.

    Do not use after expiry date.

    Terms of leave from pharmacies:Without recipe
    Registration number:P N001921 / 01
    Date of registration:12.09.2008
    Expiration Date:Unlimited
    The owner of the registration certificate:FARMAKOR PRODUCTION, LTD. FARMAKOR PRODUCTION, LTD. Russia
    Manufacturer: & nbsp
    Representation: & nbspFARMAKOR PRODUCTION LLC FARMAKOR PRODUCTION LLC Russia
    Information update date: & nbsp25.02.2017
    Illustrated instructions
      Instructions
      Up